WallStSmart
MTVA

MetaVia Inc.

NASDAQ: MTVA · HEALTHCARE · BIOTECHNOLOGY

$1.19
-1.11% today

Updated 2026-06-03

Market cap
$7.64M
P/E ratio
P/S ratio
EPS (TTM)
$-4.21
Dividend yield
52W range
$1 – $19
Volume
4.6M

MetaVia Inc. (MTVA) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-195.10%
ROA
-65.30%
Debt/equity
0.02x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2014$-320000.00
2015$-9.03M
2016$-14.59M
2017$-33.41M
2018$-15.53M
2019$-21.31M
2020$0.00$-29.68M
2021$0.00$-15.28M
2022$0.00$-13.97M
2023$0.00$-12.47M
2024$0.00$-27.59M
2025$0.00$-12.97M

Frequently asked questions

How much free cash flow does MTVA generate?

MTVA produced $-15.70M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MTVA's balance sheet healthy?

MTVA holds $10.28M in cash and equivalents against — in long-term debt, on $5.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.